Recognition of illness associated with the intentional release of a biologic agent

Back to Previous Page

retired

This Document Has Been Retired.

Recognition of illness associated with the intentional release of a biologic agent

Published Date:

October 19, 2001

Source:

MMWR. Morbidity and mortality weekly report. 2001; 50(41):893-7.

Language:

English

[HTM]

This is an HTML document so it cannot be previewed.

To open, click the "View" button.

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Description:

On September 11, 2001, following the terrorist incidents in New York City and Washington, D.C., CDC recommended heightened surveillance for any unusual disease occurrence or increased numbers of illnesses that might be associated with the terrorist attacks. Subsequently, cases of anthrax in Florida and New York City have demonstrated the risks associated with intentional release of biologic agents. This report provides guidance for health-care providers and public health personnel about recognizing illnesses or patterns of illness that might be associated with intentional release of biologic agents.

Subject:

[+]

Pubmed ID:

11686473

Document Type:

Journal Article

Place as Subject:

United States

Collection(s):

Guidelines and Recommendations

Main Document Checksum:

[+]

File Type:

Supporting Files:

No Additional Files

No Related Documents.

Syndromic Surveillance and Bioterrorism-related Epidemics

[PDF - 317.67 KB]

Personal Author:

Buehler, James W. ; Berkelman, Ruth L. ; ...

Published Date:

Oct 2003

Source:

Emerg Infect Dis. 9(10):1197-1204.

File Type:

[PDF - 317.67 KB]

File Type:

[PDF - 317.67 KB]
Lessons Learned about Pneumonic Plague Diagnosis from 2 Outbreaks, Democratic Republic of the Congo

[PDF - 245.08 KB]

Personal Author:

Bertherat, Eric ; Thullier, Philippe ; ...

Published Date:

May 2011

Source:

Emerg Infect Dis. 17(5):778-784.

Description:

Pneumonic plague is a highly transmissible infectious disease for which fatality rates can be high if untreated; it is considered extremely lethal. Wi...

File Type:

[PDF - 245.08 KB]

File Type:

[PDF - 245.08 KB]
Collection & processing of vertebrate specimens for arbovirus studies

[PDF - 30.66 MB]

Personal Author:

Sudia, W. Daniel. ; Lord, Rexford D. ; ...

Corporate Authors:

National Communicable Disease Center (U.S.)

Published Date:

January 1970

Description:

"The main purpose of this manual to to explain and illustrate techniques used by NCDC in obtaining blood and tissues from man and other vertebrates fo...

File Type:

[PDF - 30.66 MB]

File Type:

[PDF - 30.66 MB]
IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias Between a Reference Material and Clinical Samples

[PDF - 671.31 KB]

Personal Author:

Nilsson, Göran ; Budd, Jeffrey R. ; ...

Published Date:

January 18 2018

Source:

Clin Chem. 64(3):455-464

Description:

A process is described to assess the commutability of a reference material (RM) intended for use as a calibrator, trueness control, or external qualit...

File Type:

[PDF - 671.31 KB]

File Type:

[PDF - 671.31 KB]
National Health and Nutrition Examination Survey (NHANES) : MEC laboratory procedures manual

[PDF - 15.36 MB]

Corporate Authors:

National Health and Nutrition Examination Survey (U.S.) ; National Center for Health Statistics (U.S.) ;

Published Date:

January 2016

Series:

National Health and Nutrition Examination Survey (NHANES)

Description:

The laboratory component of NHANES includes the collection, processing, storage, and shipping of blood, urine, and other biological and environmental ...

File Type:

[PDF - 15.36 MB]

File Type:

[PDF - 15.36 MB]

Recognition of illness associated with the intentional release of a biologic agent

retired

Recognition of illness associated with the intentional release of a biologic agent

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC